Remove academic-and-government
article thumbnail

STAT+: After years of lax oversight, the NIH is starting to contact institutions about unreported clinical trial results

STAT News

In recent weeks, the National Institutes of Health has begun emailing academic institutions that failed to submit results of clinical trials to a government database, a move that comes shortly after a federal watchdog harshly criticized the agency for lax oversight. Continue to STAT+ to read the full story…

article thumbnail

Grand Rounds Ethics and Regulatory Series September 9, 2022: Building An Academic Learning Health System: Why Is It So Hard? (Steven Joffe, MD, MPH)

Rethinking Clinical Trials

Academic medical institutions may seem like the natural setting to build Learning Health Systems (LHS), but they face unique structural barriers that require leadership, focus, and intentionality to overcome. How does your org approach governance and oversight of learning within your LHS? Steven Joffe, MD, MPH. Key Points.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can Singapore become a global hub for biotech?

Drug Discovery World

With government support and strong academic institutions, does Singapore have what it takes to become a global centre for life sciences? Thanks to significant investment by the government into research and development, Singapore has become a leading centre for biomedical sciences in Asia.

article thumbnail

STAT+: A ‘blank check’: Bill to boost antibiotic development blasted as a ‘flawed’ giveaway to pharma

STAT News

Amid mounting concern over antibiotic resistance, a coalition of academics and advocacy groups is urging Congress not to pass legislation to reward drug companies for developing new treatments, because they argue the bill fails to require acceptable clinical trial standards and is tantamount to a giveaway to the pharmaceutical industry.

article thumbnail

STAT+: Senator calls for probe of conflict of interest on federal panel overseeing dietary guidelines

STAT News

lawmaker wants the federal government to probe potential conflicts of interest held by members of a panel created to set dietary guidelines after learning one panelist was a paid consultant to a drug company that sells weight loss treatments. Continue to STAT+ to read the full story…

Drugs 98
article thumbnail

University of Sydney will use AI to boost cancer drug research

Pharmaceutical Technology

The drug discovery initiative is an interdisciplinary academic effort to expedite early-stage drug development. In March 2023, a consortium led by the University of Sydney received A$2.5m ($1.68m) from the New South Wales (NSW) government to accelerate drug discovery and design using stem-cell-derived organoids.

Research 147
article thumbnail

Commencement of full operation of research data management platform “GakuNin RDM”

Scienmag

to support management/sharing of research data among Japanese academic institutions nationwide Credit: © National Institute of Informatics NII developed GakuNin RDM in response to the Japanese government’s policy on science and technology, as well as the international trend toward open science.